Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of NMR-based Serum Metabolic Profiles for the Diagnosis of Checkpoint Inhibitor-related Pneumonitis

NCT07340892 is registered in ClinicalTrials.gov with Zhou Chengzhi as lead sponsor.

NCT NCT07340892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07340892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of NMR-based Serum Metabolic Profiles for the Diagnosis of Checkpoint Inhibitor-related Pneumonitis
Lead sponsor
Zhou Chengzhi
Phase
Observational
Overall status
Recruiting
Start date
January 10, 2026
Completion date
January 10, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

checkpoint inhibitor-related pneumonitis